Preparing for the Next Plague

SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges

Related Keywords

Mexico ,Australia ,University Of Washington ,Washington ,United States ,Shanghai ,China ,North Carolina ,Fort Detrick ,Maryland ,Boston ,Massachusetts ,Virginia ,Wuhan ,Hubei ,Duke University ,Jeffry Ulmer ,Andrea Carfi ,Eli Lilly ,Carl Hansen ,Joe Biden ,David Veesler ,David Martinez ,Abcellera Biologics ,Medimmune Astrazeneca ,Jamy Jenkins ,James Crowe ,Jacob Glanville ,Neil King ,Nancy Sullivan ,Bolyn Hubby ,Adam Simpson ,Tillman Gerngross ,Junshi Biosciences ,Nick Jackson ,Glaxosmithkline ,Amgen ,Melinda Gates Foundation ,University Of North Carolina ,Coalition For Epidemic Preparedness Innovations ,Novartis ,Biodefense Center ,Astrazeneca ,Vanderbilt Vaccine Center ,Vanderbilt University ,Us National Institutes For Autoimmunity ,University Of Washington Institute Protein Design ,Us Naval Medical Research Center ,Vaccine Research Center ,Us Defense Advanced Research Projects Agency ,Biodefense Research Section ,Drug Administration ,University Of Wisconsin ,University Of Pennsylvania ,Gates Foundation ,West Africa ,Infectious Disease ,Advanced Research Projects Agency ,Middle Eastern Respiratory Syndrome ,Protein Design ,Vir Biotechnology ,Epidemic Preparedness Innovations ,Autonomous Diagnostics ,Enable Prevention ,Vaccine Center ,Pandemic Prevention Platform ,Cellera Biologics ,Emergency Use Authorization ,Shanghai Junshi ,Medical Research Center ,Skip Virgin ,Global Pandemic Prevention ,Emergent Biosolutions ,Advanced Human Epidemic Antibody Defenses ,Nucleic Acids ,Demand Worldwide , ,